Concomitant initiation of antihypertensive and lipid-lowering therapy, along with reducing pill burden, can significantly improve adherence in patients.
Does concomitant initiation and reduced pill burden improve adherence in patients prescribed antihypertensive and lipid-lowering therapy?
Patients prescribed concomitant antihypertensive (AH) and lipid-lowering (LL) therapy
Concomitant initiation of AH and LL therapy and reducing pill burden
Adherence to AH and LL therapy
Adherence to concomitant antihypertensive and lipid-lowering therapy is poor but may be improved by concomitant initiation and reducing pill burden.
Absolute Event Rate: 0% vs 0%
Adherence with concomitant AH and LL therapy is poor, with only 1 in 3 patients adherent with both medications at 6 months. Physicians may be able to significantly improve adherence by initiating AH and LL therapy concomitantly and by reducing pill burden.
Building similarity graph...
Analyzing shared references across papers
Loading...
Richard H. Chapman
Sutter Health
Archives of Internal Medicine
Building similarity graph...
Analyzing shared references across papers
Loading...
Richard H. Chapman (Mon,) reported a other. Concomitant initiation of antihypertensive and lipid-lowering therapy, along with reducing pill burden, can significantly improve adherence in patients.
synapsesocial.com/papers/697a2e26d8b63e6fafa6a58b — DOI: https://doi.org/10.1001/archinte.165.10.1147